Literature DB >> 11922731

Effect of blood flow occlusion on laser hyperthermia for liver metastases.

V Muralidharan1, C Malcontenti-Wilson, Chris Christophi.   

Abstract

BACKGROUND: Interstitial laser hyperthermia (ILH) is an in situ ablative technique for the treatment of colorectal liver metastases. A significant factor limiting tumor destruction is hepatic blood flow. Modulation of hepatic blood flow may increase the size of tumor necrosis achieved. Our aim was to investigate the effect of blood flow occlusion on ILH-induced necrosis in both tumor and normal liver tissue.
MATERIALS AND METHODS: A model of colorectal liver metastases in male inbred CBA mice was used. ILH was applied to normal liver and tumor tissue using a bare optical quartz fiber from an SYL500 Nd:YAG surgical laser generator, with and without hepatic blood flow occlusion, and the extent of necrosis was studied. Tumor blood flow was assessed by laser Doppler flowmetry and scanning electron microscopy.
RESULTS: Hepatic blood flow occlusion resulted in a significant reduction in blood flow in normal liver tissue (37.9% +/- 5.8, P < 0.001) and in the periphery of the tumor (17.5% +/- 7.8, P < 0.001). It did not affect the blood flow in the center of the tumor (13.4% +/- 4.3, P = 0.07). ILH of normal liver tissue, at low power (2 W), with hepatic blood flow occlusion, resulted in a significant increase in the diameter of necrosis. This effect was not seen when higher power (5 W) was used in normal liver. No significant effect was noted within tumor tissue at either power setting.
CONCLUSION: The overall effect of hepatic blood flow occlusion in ILH-induced tissue necrosis appears to be negligible in tumor tissue. Its main applicability appears to be at the tumor-host interface, where a decrease in blood flow may lead to higher temperatures and therefore to a greater degree of tumor cell destruction.

Entities:  

Mesh:

Year:  2002        PMID: 11922731     DOI: 10.1006/jsre.2002.6365

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

Review 1.  Laser ablation of hepatocellular carcinoma--a review.

Authors:  Antony Lawrence Gough-Palmer; Wladyslaw Michal Witold Gedroyc
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

Review 2.  Thermal ablation of tumours: biological mechanisms and advances in therapy.

Authors:  Katrina F Chu; Damian E Dupuy
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

3.  Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.

Authors:  Theodora Fifis; Caterina Malcontenti-Wilson; Jason Amijoyo; Beatrice Anggono; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

Review 4.  EUS-RFA of the pancreas: where are we and future directions.

Authors:  Lakshmi Asritha Gollapudi; Amy Tyberg
Journal:  Transl Gastroenterol Hepatol       Date:  2022-04-25

5.  Effect of interstitial laser hyperthermia in a murine model of colorectal liver metastases: scanning electron microscopic study.

Authors:  Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Caterina Malcontenti-Wilson; Christopher Christophi
Journal:  World J Surg       Date:  2003-12-05       Impact factor: 3.352

6.  Laser ablation for small hepatocellular carcinoma.

Authors:  Claudio Maurizio Pacella; Giampiero Francica; Giovanni Giuseppe Di Costanzo
Journal:  Radiol Res Pract       Date:  2011-12-04

7.  Noninvasive Dynamic Imaging of Tumor Early Response to Nanoparticle-mediated Photothermal Therapy.

Authors:  Fan Zhang; Jianbo Cao; Xiao Chen; Kai Yang; Lei Zhu; Guifeng Fu; Xinglu Huang; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-10-18       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.